Aehr Test Systems AEHR
104.39
6.97
7.15%
as of 25 Sep
- Market cap
- $3.3B
- P/E
- 0.0×
Follow AEHR
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(5.43%) | (6.97%) | (8.68%) | (4.16%) | |
| (4.59%) | (6.09%) | (7.54%) | (3.61%) | ||
ROIC |
(6.21%) | (8.15%) | (9.91%) | (8.57%) | |
Return on Tangible Assets |
(8.20%) | (9.97%) | (11.84%) | (4.06%) | |
Average Days of Receivables |
83.87 | 70.48 | 95.24 | 127.55 | |
Free Cash Flow per Share |
(0.54) | (0.39) | (0.40) | (0.18) | |
Free Cash Flow |
(16.25) | (11.69) | (12.19) | (5.38) | |
Capital Expenditures |
(6.19) | (6.33) | (4.75) | (2.07) | |
Piotroski F-Score |
1.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(6.93%) | (3.32%) | (4.24%) | (0.99%) | |
Accounts Receivable Turnover |
5.26 | 6.05 | 3.80 | 3.16 | |
Accounts Payable Turnover |
8.10 | 8.46 | 6.92 | 4.80 | |
Inventory Turnover |
0.85 | 0.82 | 0.75 | 0.78 | |
Average Days of Payables |
34.04 | 36.45 | 24.48 | 76.20 | |
Days of Inventory on Hand |
421.38 | 438.89 | 479.22 | 466.59 | |
Tax Rate |
(0.16) | (0.20) | (0.20) | (0.39) | |
Research and Development Expense of Revenue |
19.27% | 21.87% | 25.80% | 25.27% | |
Selling, General and Administrative Expense of Revenue |
32.46% | 34.25% | 38.69% | 38.32% | |
Share Based Compensation of Revenue |
10.49% | 12.64% | 13.96% | 13.52% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.51 | 0.61 | 0.65 | 0.46 | |
Depreciation/Fixed assets |
0.42 | 0.41 | 0.40 | 0.39 | |
Capex/Depreciation |
(1.65) | (1.70) | (1.29) | (0.59) | |
Revenue per Share |
1.90 | 1.76 | 1.47 | 1.63 | |
Operating CF per Share |
(0.34) | (0.18) | (0.24) | (0.11) | |
Capex per Share |
(0.21) | (0.21) | (0.15) | (0.07) | |
Capex to Sales |
0.11 | 0.12 | 0.11 | 0.04 | |
Net Profit Margin |
(11.71%) | (16.63%) | (25.23%) | (14.25%) |
Columns are period end dates